姚念廷,郑乾,冯占辉,尹建红,徐子茜,焦玲,张春林
YAO Nianting,ZHENG Qian,FENG Zhanhui,YIN Jianhong,XUN Ziqian,JIAO Ling,ZHANG Chunling

• 1:贵州医科大学附院神经内科
• 2:贵州医科大学
• 3:贵州医科大学基础医学院

摘要(Abstract)：

目的:探讨舞蹈病-棘红细胞增多症(Ch Ac)的诊断方法及家系特点,为Ch Ac的精准诊断提供可行合理的策略。方法:选取1例临床疑似Ch Ac患者(先证者)作为研究对象,收集其临床资料和家系资料并绘制遗传家系图;采用扫描电镜检测棘红细胞,利用全外显子目标序列捕获2代测序技术筛查Ch Ac易患性基因及其突变类型。结果:先证者主要临床表现为不自主伸舌、磨牙、扮鬼脸、头部及四肢舞蹈动作及口唇自噬动作,外周血肌酶和转氨酶均增高,头颅MRI可见尾状核轻度萎缩;其兄生前具有与先证者同样的临床表现,其父母及姐姐均体健;先证者外周血检测到典型棘红细胞,检测出液泡蛋白分类同源物13A(VPS13A)基因,且VPS13A基因存在c. 9403C> T纯合突变,引起氨基酸改变p. R3135X,为无义突变;先证者的父亲和母亲均为c. 9403C> T杂合突变。结论:结合临床表现及扫描电镜检查可以高度怀疑Ch Ac,但全外显子目标序列捕获2代测序技术可准确检测VPS13A基因突变,并可结合遗传家系特点,作为Ch Ac首选确诊手段。
Objective: To explore the diagnosis method and family characteristics of choreaacanthocytosis( ChAc),and provide feasible and reasonable strategies for accurate diagnosis of ChAc.Methods: A clinically suspected ChAc patient( proband) was selected as the study object,the clinical and family datas of the proband were collected and a genetic family map was drawn. Then,acanthocytes were detected by scanning electron microscopy,and the susceptibility genes and mutation types of ChAc were screened by total exon target sequence capture next-generation sequencing technology. Results: The main clinical manifestations of this proband were involuntary tongue extension,molar grinding,grimace,head and limb dance movements,and lip autophagy. Creatine kinase and aminotransferases were increased,brain MRI showed slight atrophy of the caudate nucleus.His brother had the same clinical manifestations as the proband before his death,and his parents and sister were healthy. Typical acanthocytes were detected by scanning electron microscopy in peripheral blood. More importantly,the vacuolar protein sorting homolog 13 A( VPS13 A) gene was detected,and there was c. 9403 C > T homozygous mutation in VPS13 A gene,which caused changes in p. R3135 X,thereby it was a nonsense mutation; his parents displayed a heterozygous mutation of the same genetic mutation. Conclusion: ChAc can be highly suspected by clinical data and acanthocytes. However,total exon target sequence capture next-generation sequencing technology can accurately detect VPS13 A gene mutation,and can be combined with the characteristics of genetic families. Therefore,it can be used as the first choice for diagnosis of ChAc.

关键词(KeyWords)： 诊断;棘红细胞;基因表达;舞蹈病-棘红细胞增多症;高通量2代测序技术;VPS13A基因
diagnosis;acanthocytes;gene expression;chorea-acanthocytosis(ChAc);high-throughput next-generation sequencing technology;VPS13A gene

Abstract:

Keywords:

基金项目(Foundation): 传染病预防控制国家重点实验室自主研究开放课题(2018SKLID307);; 贵州省卫生健康委科学技术基金项目(gzwjkj2019-1-065);; 贵州省科技厅[黔科合平台人才(2017)5718];; 贵阳市科技计划项目[筑科合同(2017)30-30]

作者(Author): 姚念廷,郑乾,冯占辉,尹建红,徐子茜,焦玲,张春林
YAO Nianting,ZHENG Qian,FENG Zhanhui,YIN Jianhong,XUN Ziqian,JIAO Ling,ZHANG Chunling

DOI: 10.19367/j.cnki.1000-2707.2020.03.020

参考文献(References)：

• [1] RAMPOLDI L,DANEK A,MONACO A P. Clinical features and molecular bases of neuroacanthocytosis[J].Journal of Molecular Medicine,2002,80(8):475-491.
• [2]VERKKONIEMIAHOLA A,KUULUVAINEN L,KIVIRIKKO S,et al. Chorea-acanthocytosis associated with two novel heterozygous mutations in the VPS13A gene[J]. Journal of the Neurological Sciences,2019,408:116555.
• [3] NISHIDA Y,NAKAMURA M,URATA Y,et al. Novel pathogenic VPS13A gene mutations in Japanese patients with Chorea-acanthocytosis[J]. Neurology Genetics,2019,5(3):e332.
• [4]PEIKERT K,DANEK A,HERMANN A. Current state of knowledge in Chorea-acanthocytosis as core Neuroacanthocytosis syndrome[J]. European Journal of Medical Genetics,2018,61(11):699-705.
• [5]SHEN Y,LIU X,LONG X,et al. Novel VPS13A gene mutations identified in patients diagnosed with Chorea-acanthocytosis(Ch Ac):case presentation and literature review[J]. Frontiers in Aging Neuroscience,2017,9:95.
• [6]MENTE K,KIM S A,GRUNSEICH C,et al. Hippocampal sclerosis and mesial temporal lobe epilepsy in Choreaacanthocytosis:a case with clinical,pathologic,and genetic evaluation[J]. Neuropathology and Applied Neurobiology,2017,43(6):542-546.
• [7]万亚楠，陶雯，顾晓苏，等．舞蹈病-棘红细胞增多症(附1例报告及文献复习)[J]．中国临床神经科学，2018,26(5):555-558; 587.
• [8] XIANG Y,LI S,LIU X,et al. Neuroacanthocytosis:a case report of Chorea-acanthocytosis[J]. Journal of Integrative Neuroscience,2019,18(2):197-201.
• [9]ZHU H,FENG X M,ZHAO T,et al. Neuroacanthocytosis with unusual clinical features[J]. Medicine,2019,98(2):e14050.
• [10]LIU Y,LIU Z Y,WAN X H,et al. Progress in the diagnosis and management of Chorea-acanthocytosis.[J].Chinese Medical Sciences Journal,2018,33(1):53-59.
• [11]YI F,LI W,XIE N,et al. Chorea-acanthocytosis in a Chinese family with a pseudo-dominant inheritance mode[J]. Frontiers in Neurology,2018,9:594.
• [12]ROULIS E,HYLAND C,FLOWER R,et al. Molecular basis and clinical overview of McLeod syndrome compared with other Neuroacanthocytosis syndromes:a review[J].JAMA Neurology,2018,75(12):1554-1562.
• [13]孙一忞，章悦．遗传性舞蹈病的诊断思路和基因筛查策略(附3例报告及文献复习)[J]．中国临床神经科学，2017,25(5):519-527.
• [14]郭丹丹，柏雪．神经-棘红细胞增多症[J]．世界最新医学信息文摘，2019,19(82):297-298.
• [15]WALKER R H. Untangling the thorns:advances in the Neuroacanthocytosis syndromes[J]. Journal of Movement Disorders,2015,8(2):41-54.
• [16]BENNINGER F,AFAWI Z,KORCZYN A D,et al. Seizures as presenting and prominent symptom in Chorea-acanthocytosis with c. 2343del VPS13A gene mutation[J].Epilepsia:Journal of the International League against Epilepsy,2016,57:549-56.
• [17]PELUSO S,BILO L,ESPOSITO M,et al. Chorea-acanthocytosis without chorea:expanding the clinical phenotype[J]. Parkinsonism&Related Disorders,2017,41:124-126.
• [18]WEBER J,FRINGS L,RIJNTJES M,et al. Chorea-acanthocytosis presenting as autosomal recessive epilepsy in a family with a novel VPS13A mutation[J]. Frontiers in Neurology,2018,9:1168.
• [19]ALESUTAN I,SEIFERT J,PAKLADOK T,et al. Chorein sensitivity of actin polymerization,cell shape and mechanical stiffness of vascular endothelial cells[J]. Cellular Physiology and Biochemistry,2013,32:728-42.
• [20]RZEPNIKOWSKA W,FLIS K,MUNOZ-BRACERAS S,et al. Yeast and other lower eukaryotic organisms for studies of VPS13 proteins in health and disease[J]. Traffic,2017,18(11):711-719.
• [21]GLAB H,PAL A,REINHARDT P,et al. Defective mitochondrial and lysosomal trafficking in Chorea-acanthocytosis is independent of src-kinase signaling[J]. Molecular and Cellular Neurosciences,2018,92:137-148.
• [22]WEAVER J,SARVA H,BARONE D,et al. McLeod syndrome:five new pedigrees with novel mutations[J]. Parkinsonism&Related Disorders,2019,64:293-299.
• [23]ANDERSON D G,WALKER R H,CONNOR M,et al. A systematic review of the Huntington disease-like 2 phenotype[J]. Journal of Huntingtons Disease,2017,6:37-46.
• [24]FERREIRACORREIA A,ANDERSON D G,COCKCROFT K,et al. The neuropsychological deficits and dissociations in Huntington disease-like 2:a series of case-control studies[J]. Neuropsychologia,2020,136:107238.
• [25]SCHIESSLWEYER J,ROA P,LACCONE F,et al. Acanthocytosis and the c. 680 A> G mutation in the PANK2gene:a study enrolling a cohort of PKAN patients from the dominican republic[J]. Plos One,2015,10:e0125861.
• [26]ZHANG Y,ZHOU D,YANG T. Novel PANK2 mutation in a Chinese boy with PANK2-associated neurodegeneration:a case report and review of Chinese cases[J]. Medicine,2019,98(4):14122.

文章评论(Comment)：